524558 logo

Neuland Laboratories Stock Price

Symbol: BSE:524558Market Cap: ₹167.3bCategory: Pharmaceuticals & Biotech

524558 Share Price Performance

₹13,073.10
2105.25 (19.19%)
18.3% undervalued intrinsic discount
₹16,005.00
Fair Value
₹13,073.10
2105.25 (19.19%)
18.3% undervalued intrinsic discount
₹16,005.00
Fair Value
Price ₹13,073.10
AnalystConsensusTarget ₹16,005.00

524558 Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value ₹16.01k 18.3% undervalued intrinsic discount

Enhancing Peptide Capacity Will Tap Into Expanding Market For Peptide Therapies

1users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Community Fair Values

Recent 524558 News & Updates

No updates

Neuland Laboratories Limited Key Details

₹13.3b

Revenue

₹6.9b

Cost of Revenue

₹6.4b

Gross Profit

₹4.6b

Other Expenses

₹1.8b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
137.29
Gross Margin
48.09%
Net Profit Margin
13.24%
Debt/Equity Ratio
10.3%

Neuland Laboratories Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About 524558

Founded
1984
Employees
1794
CEO
Davuluri Rao
WebsiteView website
www.neulandlabs.com

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Indian Market Performance

  • 7 Days: -1.6%
  • 3 Months: 2.7%
  • 1 Year: -6.5%
  • Year to Date: -2.0%
Over the last 7 days, the market has dropped 1.6%, driven by a pullback of 2.1% in the Financials sector. In the last 12 months the market is down 6.5%. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading